# Bionexus Gene Lab Corp. (BGLC) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$3M |
| 2024 | -$2M |
| 2023 | -$3M |
| 2022 | -$291,177 |
| 2021 | $1M |
| 2020 | $1M |
| 2019 | -$275,705 |
| 2018 | $59,901 |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$540,490 |
| 2025-09-30 | -$702,509 |
| 2025-06-30 | -$611,293 |
| 2025-03-31 | -$618,418 |
| 2024-09-30 | -$1M |
| 2024-06-30 | $259,168 |
| 2024-03-31 | -$79,028 |
| 2023-09-30 | -$3M |
| 2023-06-30 | -$272,199 |
| 2023-03-31 | -$50,631 |
| 2022-09-30 | -$65,215 |
| 2022-06-30 | -$137,964 |
| 2022-03-31 | $34,691 |
| 2021-09-30 | $372,641 |
| 2021-06-30 | $139,990 |
| 2021-03-31 | $342,102 |
| 2020-09-30 | $237,306 |
| 2020-06-30 | -$33,974 |
| 2020-03-31 | $1M |
| 2019-09-30 | -$50,138 |
| 2019-06-30 | -$69,219 |
| 2019-03-31 | -$60,203 |
| 2018-09-30 | -$55,142 |
| 2018-06-30 | -$39,472 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BGLC/operating-income)